Klein Helmut U, Cygankiewicz Iwona, Jons Christian, Buhtz Frank, Szymkiewicz Steven
Heart Research Follow up Program, University of Rochester Medical Center, Box 653, 601 Elmwood Avenue, Rochester, NY 14642, USA.
CORIZON Gmbh, Heinrich-Hertz-Strasse 6, 50170 Kerpen, Germany.
Card Electrophysiol Clin. 2009 Dec;1(1):129-146. doi: 10.1016/j.ccep.2009.08.007. Epub 2009 Oct 23.
The wearable cardioverter defibrillator (WCD) was introduced into clinical practice about 8 years ago as an alternative approach to protect patients with a temporary high risk of sudden arrhythmic death. The WCD has the characteristics of an implantable defibrillator (ICD) but does not need to be implanted, and it has similarities with an external defibrillator, but does not require a bystander to apply lifesaving shocks when necessary. Based on current clinical experience, the WCD is not an alternative to the ICD, but a device that will contribute to better selection of patients for ICD therapy and may be indicated in case of interrupted protection by an already implanted ICD, temporary inability to implant an ICD, or refusal of an indicated ICD.